ARCT Arcturus Therapeutics Holdings Inc. - Common Stock
$9.95
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$6–$24
24% of range
分析师评级
BUY
18 analysts
目标价
$20
+103% upside
P/E (TTM)
-4.1
ROE
-29.6%
净利润率
-80.2%
ARCT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$9.95
市值
$283M
P/E (TTM)
-4.1
每股收益 (TTM)
$-2.40
营收 (TTM)
$82M
股息收益率
—
ROE
-29.6%
负债/权益
—
52周区间
$6 – $24
ARCT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$82M
2018-12-31
→
2025-12-31
EPS
$-2.40
2021-12-31
→
2025-12-31
自由现金流
$-75M
2019-12-31
→
2025-12-31
利润率
-80.2%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ARCT
同行中位数
P/E (TTM)
-4.1
—
P/S (TTM) (市销率 (TTM))
3.4
9.2
P/B (市净率)
1.3
1.5
Price / FCF (股价/自由现金流)
-3.8
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ARCT
同行中位数
Operating Margin (营业利润率)
-93.0%
—
Net Profit Margin (净利润率)
-80.2%
-317.6%
ROA
-21.4%
-40.7%
ROE
-29.6%
-64.1%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ARCT
同行中位数
Current Ratio (流动比率)
6.6
10.4
Quick Ratio (速动比率)
6.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ARCT
同行中位数
Revenue YoY (营收同比增长)
-46.1%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-26.4%
—
Revenue CAGR 5Y (营收5年复合年增长率)
53.8%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ARCT
同行中位数
ARCT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
18 位分析师
- 强烈买入 5 27.8%
- 买入 9 50.0%
- 持有 4 22.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
10 位分析师 · 2026-08-15
中位数
$20.00
现在
$9.95
最低
$8.00
最高
$40.00
中位数目标
$20.00
+101.1%
平均目标
$20.20
+103.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.30%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.84 | $-1.02 | 0.18% |
| 2026年3月31日 | $-0.95 | $-1.11 | 0.16% |
| 2025年12月31日 | $-1.03 | $-0.73 | -0.30% |
| 2025年9月30日 | $-0.49 | $-0.84 | 0.35% |
| 2025年6月30日 | $-0.34 | $-0.91 | 0.57% |
| 2025年3月31日 | $-0.52 | $-1.36 | 0.84% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| SRZN | — | — | — | — | — | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| ZSQR | — | — | — | — | — | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $82M | $152M | $167M | $206M | $12M | $10M | $21M | $16M | |
| R&D Expense | $112M | $195M | $192M | $148M | $174M | $58M | $34M | $17M | |
| SG&A Expense | $46M | $53M | $53M | $46M | $41M | $23M | $13M | $21M | |
| Operating Expenses | $158M | $248M | $245M | $194M | $215M | $81M | $46M | $38M | |
| Operating Income | $-76M | $-96M | $-78M | $12M | $-203M | $-72M | $-26M | $-22M | |
| Other Non-op | $10M | $15M | $17M | $-420.0K | $-2M | $-361.0K | $-446.0K | $328.0K | |
| Pretax Income | $-66M | $-81M | $-28M | $11M | $-204M | $-72M | $-26M | $-22M | |
| Income Tax | · | $-4.0K | $2M | $1M | · | · | · | · | |
| Net Income | $-66M | $-81M | $-30M | $9M | $-204M | $-72M | $-26M | $-22M | |
| EPS (Basic) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 | · | · | · | |
| EPS (Diluted) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 | · | · | · | |
| Shares (Basic) | 27,386,000 | 27,000,000 | 26,628,000 | 26,445,000 | 26,317,000 | · | · | · | |
| Shares (Diluted) | 27,386,000 | 27,000,000 | 26,628,000 | 27,093,000 | 26,317,000 | · | · | · | |
| EBITDA | $-76M | $-96M | $-78M | $12M | $-203M | $-72M | $-26M | · |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $231M | $237M | $292M | $392M | $370M | $463M | $71M | $37M | |
| Receivables | $6M | $4M | $32M | $3M | $3M | $2M | $2M | $4M | |
| Prepaid Expense | · | · | · | · | · | · | $720.0K | $546.0K | |
| Other Current Assets | · | · | · | · | · | · | $38.0K | $92.0K | |
| Current Assets | $241M | $306M | $387M | $403M | $379M | $468M | $74M | $42M | |
| PP&E (Net) | $7M | $10M | $12M | $12M | $6M | $3M | $2M | $2M | |
| PP&E (Gross) | $19M | $21M | $21M | $18M | $10M | $6M | $5M | $3M | |
| Accum. Depreciation | $12M | $12M | $9M | $6M | $4M | $3M | $2M | $1M | |
| Total Assets | $271M | $344M | $429M | $450M | $393M | $476M | $82M | $44M | |
| Accounts Payable | $4M | $7M | $5M | $7M | $10M | $11M | $6M | $2M | |
| Accrued Liabilities | $24M | $39M | $32M | $30M | $24M | $19M | $7M | $4M | |
| Current Liabilities | $36M | $65M | $82M | $127M | $100M | $50M | $21M | $13M | |
| Capital Leases | $21M | $25M | $26M | $30M | $5M | $4M | $5M | · | |
| Other Non-current Liabilities | · | · | $497.0K | $3M | · | · | · | · | |
| Total Liabilities | $57M | $103M | $151M | $180M | $165M | $80M | $56M | $31M | |
| Long-term Debt | · | · | · | · | $15M | $15M | $15M | · | |
| Total Debt | · | · | · | $61M | $63M | $15M | $15M | · | |
| Common Stock | $28.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $15.0K | $214.0K | |
| Paid-in Capital | $729M | $690M | $646M | $608M | $576M | $540M | $97M | $58M | |
| Retained Earnings | $-515M | $-449M | $-368M | $-338M | $-347M | $-144M | $-72M | $-45M | |
| Stockholders' Equity | $214M | $241M | $279M | $270M | $228M | $397M | $26M | $14M | |
| Liabilities + Equity | $271M | $344M | $429M | $450M | $393M | $476M | $82M | $44M | |
| Shares Outstanding | 28,414,000 | 27,000,000 | 26,828,000 | 26,555,000 | 26,372,000 | 26,192,000 | 15,138,000 | 10,719,000 |
现金流 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $3M | $2M | $1M | $882.0K | $684.0K | $582.0K | |
| Stock-based Comp | $25M | $38M | $35M | $31M | $29M | $7M | $2M | $1M | |
| Operating Cash Flow | $-74M | $-60M | $-18M | $32M | $-135M | $-43M | $-6M | $-21M | |
| CapEx | $230.0K | $648.0K | $3M | $8M | $3M | $2M | $818.0K | $1M | |
| Investing Cash Flow | $-230.0K | $-648.0K | $-3M | $-8M | $-3M | $-2M | $-818.0K | $22M | |
| Debt Issued | · | · | · | · | $47M | · | $5M | $10M | |
| Net Debt Issued | · | · | · | · | $47M | · | $5M | · | |
| Stock Issued | $12M | · | · | · | · | $424M | $21M | · | |
| Net Stock Activity | $12M | · | · | · | · | $424M | $21M | · | |
| Financing Cash Flow | $13M | $5M | $-24M | $-3M | $48M | $436M | $42M | $10M | |
| Net Change in Cash | $-61M | $-55M | $-45M | $21M | $-90M | $392M | $35M | $12M | |
| Taxes Paid | · | $1M | · | · | · | · | · | · | |
| Free Cash Flow | $-75M | $-60M | $-21M | $24M | $-138M | $-45M | $-7M | · |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | · | |
| Net Margin | -80.2% | -53.1% | -17.8% | 4.5% | -1648.0% | -756.4% | -125.0% | · | |
| Pretax Margin | -80.2% | -53.1% | -16.7% | 5.2% | -1648.0% | -756.4% | -125.0% | · | |
| EBITDA Margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | · | |
| ROA | -21.4% | -20.9% | -6.8% | 2.2% | -46.9% | -25.8% | -41.1% | · | |
| ROE | -29.6% | -32.2% | -10.6% | 4.5% | -83.6% | -21.9% | -84.3% | · | |
| ROIC | · | -39.7% | -29.9% | 3.2% | · | · | · | · |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 4.7 | 4.7 | 3.2 | 3.8 | 9.4 | 3.5 | · | |
| Quick Ratio | 6.5 | 3.7 | 4.0 | 3.1 | 3.8 | 9.4 | 3.4 | · | |
| Debt / Equity | · | · | · | 0.2 | 0.3 | 0.0 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | 0.2 | 0.0 | 0.6 | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.4 | 0.4 | 0.5 | 0.0 | 0.0 | 0.3 | · | |
| Receivables Turnover | 17.2 | 8.5 | 9.6 | 67.2 | 4.5 | 4.4 | 6.2 | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -46.1% | -8.7% | -19.0% | 1566.8% | 29.6% | · | · | · | |
| Revenue CAGR 3Y | -26.4% | 131.0% | 159.6% | · | · | · | · | · | |
| Revenue CAGR 5Y | 53.8% | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $82M | $152M | $167M | $206M | $12M | $10M | $21M | · | |
| Net Income TTM | $-66M | $-81M | $-30M | $9M | $-204M | $-72M | $-26M | · | |
| Market Cap | $174M | $458M | $846M | $450M | $976M | $1.14B | $165M | · | |
| Enterprise Value | · | · | · | $119M | $669M | $688M | $108M | · | |
| P/E | -2.6 | -5.7 | -28.2 | 48.5 | -4.8 | · | · | · | |
| P/S | 2.1 | 3.0 | 5.1 | 2.2 | 79.0 | 119.1 | 7.9 | · | |
| P/B | 0.8 | 1.9 | 3.0 | 1.7 | 4.3 | 2.9 | 6.4 | · | |
| P / Tangible Book | 0.8 | 1.9 | 3.0 | 1.7 | 4.3 | 2.9 | · | · | |
| P / Cash Flow | -2.3 | -7.7 | -46.7 | 14.1 | -7.2 | -26.5 | -25.5 | · | |
| P / FCF | -2.3 | -7.6 | -40.3 | 18.6 | -7.0 | -25.5 | -22.7 | · | |
| EV / EBITDA | · | · | · | 9.8 | -3.3 | -9.6 | -4.2 | · | |
| EV / FCF | · | · | · | 4.9 | -4.8 | -15.4 | -14.9 | · | |
| EV / Revenue | · | · | · | 0.6 | 54.1 | 72.2 | 5.2 | · | |
| Earnings Yield | -39.1% | -17.7% | -3.5% | 2.1% | -20.9% | · | · | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $2M | $7M | $17M | $28M | $29M | $23M | $42M | $50M | $38M | $31M | $45M | $11M | $80M | $160M | $13M | |
| R&D Expense | $18M | $22M | $24M | $23M | $30M | $35M | $44M | $39M | $59M | $54M | $37M | $51M | $53M | $52M | $27M | $38M | |
| SG&A Expense | $11M | $9M | $14M | $10M | $10M | $11M | $12M | $13M | $12M | $15M | $13M | $13M | $13M | $14M | $12M | $12M | |
| Operating Expenses | $29M | $31M | $39M | $34M | $40M | $46M | $56M | $52M | $71M | $68M | $49M | $64M | $66M | $66M | $39M | $50M | |
| Operating Income | $-26M | $-29M | $-31M | $-17M | $-12M | $-17M | $-33M | $-11M | $-21M | $-30M | $-18M | $-19M | $-55M | $15M | $121M | $-37M | |
| Other Non-op | $-59.0K | $35.0K | $2M | $3M | $-127.0K | $-21.0K | $3M | $4M | $4M | $4M | $7M | $4M | $3M | $2M | $1M | $-321.0K | |
| Pretax Income | $-24M | · | $-29M | $-13M | $-9M | $-14M | $-30M | $-7M | $-17M | $-26M | $-11M | $-15M | $-52M | $51M | $119M | $-35M | |
| Income Tax | $0 | · | · | $0 | $4.0K | $0 | $-5.0K | $-217.0K | $-150.0K | $368.0K | $262.0K | $893.0K | $577.0K | $103.0K | $1M | $0 | |
| Net Income | $-24M | $-27M | $-29M | $-13M | $-9M | $-14M | $-30M | $-7M | $-17M | $-27M | $-12M | $-16M | $-53M | $51M | $117M | $-35M | |
| EPS (Basic) | $-0.84 | $-0.95 | $-1.05 | $-0.49 | $-0.34 | $-0.52 | $-1.10 | $-0.26 | $-0.64 | $-1.00 | $-0.44 | $-0.61 | $-1.98 | $1.91 | $4.44 | $-1.33 | |
| EPS (Diluted) | $-0.84 | $-0.95 | $-1.05 | $-0.49 | $-0.34 | $-0.52 | $-1.10 | $-0.26 | $-0.64 | $-1.00 | $-0.40 | $-0.61 | $-1.98 | $1.87 | $4.44 | $-1.33 | |
| Shares (Basic) | 28,423,000 | 28,421,000 | -54,038,000 | 27,188,000 | 27,129,000 | 27,107,000 | -53,908,000 | 27,062,000 | 26,967,000 | 26,879,000 | -53,064,000 | 26,574,000 | 26,563,000 | 26,555,000 | 26,365,732 | 26,467 | |
| Shares (Diluted) | 28,423,000 | 28,421,000 | -54,038,000 | 27,188,000 | 27,129,000 | 27,107,000 | -53,908,000 | 27,062,000 | 26,967,000 | 26,879,000 | -53,658,000 | 26,574,000 | 26,563,000 | 27,149,000 | 27,013,732 | 26,467 | |
| EBITDA | $-26M | $-29M | · | $-17M | $-12M | $-17M | · | $-11M | $-21M | $-30M | · | $-19M | $-55M | $15M | · | $-37M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $191M | $211M | $231M | $180M | $196M | $217M | $237M | $237M | $260M | $288M | $292M | $312M | $323M | $328M | $392M | $238M | |
| Receivables | $2M | $1M | $6M | $8M | $17M | $15M | $4M | $30M | $24M | $27M | · | $38M | $3M | $92M | · | $2M | |
| Current Assets | $197M | $217M | $241M | $249M | $275M | $279M | $306M | $331M | $347M | $376M | · | $393M | $385M | $425M | · | $247M | |
| PP&E (Net) | $5M | $6M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | · | $13M | $13M | $13M | · | $11M | |
| PP&E (Gross) | $18M | $19M | $19M | $19M | $21M | $21M | $21M | $21M | $21M | $21M | · | $21M | $20M | $19M | · | $17M | |
| Accum. Depreciation | $13M | $13M | $12M | $12M | $13M | $13M | $12M | $11M | $10M | $9M | · | $8M | $7M | $6M | · | $5M | |
| Total Assets | $224M | $245M | $271M | $282M | $309M | $332M | $344M | $371M | $389M | $419M | · | $458M | $431M | $471M | · | $294M | |
| Accounts Payable | $4M | $4M | $4M | $5M | $11M | $6M | $7M | $10M | $14M | $9M | · | $18M | $14M | $19M | · | $18M | |
| Accrued Liabilities | $23M | $23M | $24M | $19M | $25M | $31M | $39M | $32M | $35M | $35M | · | $29M | $29M | $32M | · | $26M | |
| Current Liabilities | $34M | $34M | $36M | $32M | $47M | $49M | $65M | $69M | $92M | $115M | · | $88M | $90M | $90M | · | $76M | |
| Capital Leases | $19M | $20M | $21M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | · | $27M | $28M | $29M | · | $31M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $976.0K | $1M | $2M | · | $4M | |
| Total Liabilities | $53M | $54M | $57M | $58M | $78M | $98M | $103M | $109M | $130M | $155M | · | $178M | $145M | $142M | · | $148M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $13M | |
| Total Debt | · | · | · | · | · | $15M | · | · | · | · | · | $20M | · | · | · | $60M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | · | $27.0K | $27.0K | $27.0K | · | $26.0K | |
| Paid-in Capital | $737M | $733M | $729M | $710M | $703M | $697M | $690M | $681M | $670M | $659M | · | $636M | $625M | $617M | · | $601M | |
| Retained Earnings | $-565M | $-542M | $-515M | $-486M | $-472M | $-463M | $-449M | $-419M | $-412M | $-395M | · | $-356M | $-340M | $-287M | · | $-455M | |
| Stockholders' Equity | $172M | $191M | $214M | $225M | $231M | $234M | $241M | $262M | $259M | $264M | $279M | $280M | $285M | $329M | $270M | $146M | |
| Liabilities + Equity | $224M | $245M | $271M | $282M | $309M | $332M | $344M | $371M | $389M | $419M | · | $458M | $431M | $471M | · | $294M | |
| Shares Outstanding | 28,423,000 | 28,423,000 | 28,414,000 | 27,235,000 | 27,148,000 | · | 27,000,000 | 27,084,000 | 27,042,000 | 26,917,000 | · | 26,723,000 | 26,574,000 | 26,555,000 | · | 26,492,000 |
现金流 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $658.0K | $624.0K | $800.0K | $800.0K | $801.0K | $840.0K | $900.0K | $900.0K | $904.0K | $879.0K | $800.0K | $700.0K | $578.0K | $503.0K | $400.0K | |
| Stock-based Comp | $4M | $4M | $7M | $6M | $6M | $7M | $9M | $9M | $9M | $10M | $9M | $9M | $8M | $8M | $7M | $9M | |
| Operating Cash Flow | $-20M | $-19M | $-16M | $-17M | $-6M | $-35M | $-284.0K | $-24M | $-30M | $-6M | $-629.0K | $-32M | $51M | $-36M | $160M | $-42M | |
| CapEx | $0 | $0 | $-88.0K | $181.0K | $0 | $137.0K | $0 | $80.0K | $328.0K | $240.0K | $875.0K | $981.0K | $354.0K | $691.0K | $4M | $2M | |
| Investing Cash Flow | $18.0K | $34.0K | $88.0K | $-181.0K | $0 | $-137.0K | $0 | $-80.0K | $-328.0K | $-240.0K | $-875.0K | $-981.0K | $-354.0K | $-691.0K | $-4M | $-2M | |
| Financing Cash Flow | $0 | $16.0K | $12M | $1M | $-15M | $15M | $134.0K | $693.0K | $2M | $2M | $-19M | $22M | $94.0K | $-27M | $-2M | $-1M | |
| Net Change in Cash | $-20M | $-19M | $-4M | $-16M | $-20M | $-20M | $-150.0K | $-23M | $-28M | $-4M | $-20M | $-12M | $51M | $-64M | $154M | $-46M | |
| Free Cash Flow | · | $-19M | · | · | · | $-35M | · | · | · | $-6M | · | · | · | $-37M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -863.3% | -1403.7% | · | -96.3% | -41.0% | -57.3% | · | -25.8% | -42.4% | -80.0% | · | -42.8% | -526.4% | 18.4% | · | -275.3% | |
| Net Margin | -803.8% | -1308.3% | · | -78.4% | -32.4% | -47.9% | · | -16.6% | -34.5% | -70.5% | · | -35.9% | -499.6% | 63.2% | · | -263.8% | |
| Pretax Margin | -803.8% | · | · | -78.4% | -32.4% | -47.9% | · | -17.1% | -34.8% | -69.6% | · | -34.0% | -494.1% | 63.3% | · | · | |
| EBITDA Margin | -863.3% | -1403.7% | · | -96.3% | -41.0% | -57.3% | · | -25.8% | -42.4% | -80.0% | · | -42.8% | -526.4% | 18.4% | · | -275.3% | |
| ROA | -8.9% | -9.3% | · | -4.1% | -2.6% | -3.8% | · | -1.7% | -4.2% | -6.0% | · | -4.3% | -13.7% | 12.5% | · | -9.7% | |
| ROE | -11.8% | -12.7% | · | -5.5% | -3.8% | -5.7% | · | -2.5% | -6.3% | -9.0% | · | -7.6% | -23.1% | 19.8% | · | -17.4% | |
| ROIC | -14.9% | · | · | · | -5.0% | -6.8% | · | -4.0% | -8.1% | -11.7% | · | -6.8% | -19.6% | 4.5% | · | · |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.3 | · | 7.9 | 5.9 | 5.6 | · | 4.8 | 3.8 | 3.3 | · | 4.5 | 4.3 | 4.7 | · | 3.3 | |
| Quick Ratio | 5.8 | 6.2 | · | 5.9 | 4.6 | 4.7 | · | 3.8 | 3.1 | 2.7 | · | 4.0 | 3.6 | 4.7 | · | 3.2 | |
| Debt / Equity | · | · | · | · | · | 0.1 | · | · | · | · | · | 0.1 | · | · | · | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | · | · | · | · | · | 0.1 | · | · | · | 0.2 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.2 | · | 0.0 | |
| Receivables Turnover | 0.3 | 0.3 | · | 0.9 | 1.4 | 1.4 | · | 1.2 | 3.7 | 0.6 | · | 2.2 | 4.2 | 1.7 | · | 6.6 |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $50M | $77M | · | $117M | $149M | $159M | · | $175M | $144M | $174M | · | $149M | $131M | $126M | · | $52M | |
| Net Income TTM | $-73M | $-64M | · | $-44M | $-47M | $-65M | · | $-67M | $-113M | $-45M | · | $-53M | $-59M | $-57M | · | $-147M | |
| Market Cap | $191M | $219M | · | $502M | $353M | · | · | $629M | $658M | $909M | · | $683M | $762M | $637M | · | $393M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $391M | · | · | · | $215M | |
| P/E | -2.6 | -3.4 | · | -11.4 | -7.4 | -4.4 | · | -9.2 | -5.8 | -19.6 | · | -12.5 | -12.7 | -10.8 | · | -2.4 | |
| P/S | 3.8 | 2.9 | · | 4.3 | 2.4 | · | · | 3.6 | 4.6 | 5.2 | · | 4.6 | 5.8 | 5.1 | · | 7.6 | |
| P/B | 1.1 | 1.1 | · | 2.2 | 1.5 | · | · | 2.4 | 2.5 | 3.4 | · | 2.4 | 2.7 | 1.9 | · | 2.7 | |
| P / Tangible Book | 1.1 | 1.1 | · | 2.2 | 1.5 | · | · | 2.4 | 2.5 | 3.4 | · | 2.4 | 2.7 | 1.9 | · | 2.7 | |
| P / Cash Flow | · | -11.3 | · | · | · | · | · | · | · | -163.6 | · | · | · | -17.7 | · | · | |
| P / FCF | · | -11.3 | · | · | · | · | · | · | · | -156.8 | · | · | · | -17.4 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -20.2 | · | · | · | -5.8 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 2.6 | · | · | · | 4.2 | |
| Earnings Yield | -39.0% | -29.8% | · | -8.7% | -13.5% | -22.9% | · | -10.8% | -17.4% | -5.1% | · | -8.0% | -7.9% | -9.3% | · | -41.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $82M | $152M | $167M | $206M | $12M |
| 营业利润率 % | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% |
| 净收入 | $-66M | $-81M | $-30M | $9M | $-204M |
| 稀释后每股收益 (EPS) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | — | — | 0.2 | 0.3 |
| 流动比率 | 6.6 | 4.7 | 4.7 | 3.2 | 3.8 |
| 速动比率 | 6.5 | 3.7 | 4.0 | 3.1 | 3.8 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-75M | $-60M | $-21M | $24M | $-138M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 148 家申报者 · $152.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 26 (+1 与上一季度对比) | 8 (-14 与上一季度对比) | 51 (+4 与上一季度对比) | 38 (+3 与上一季度对比) | +2.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 17 位内幕人士 · 8 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Joseph E Payne | President and CEO | 2025年12月17日 A | 1480097 | 0 | 0 | $0 |
| Dennis Mulroy | Chief Financial Officer | 2026年5月1日 A | — | 0 | 0 | $0 |
| Andy Sassine | Chief Financial Officer | 2025年8月15日 P | 221764 | 2 | 0 | $41002 |
| Pad Chivukula | Chief Scientific Officer & COO | 2025年12月17日 A | 435334 | 0 | 0 | $0 |
| Joseph Roberts | Controller | 2025年12月17日 A | — | 0 | 0 | $0 |
| Lance Kurata | Chief Legal Officer | 2025年12月17日 A | — | 0 | 0 | $0 |
| Keith C Kummerfeld | Senior Vice President of Finance (Principal Accounting Officer) | 2023年12月15日 A | 950 | 0 | 0 | $0 |
| Steven George Hughes | Chief Development Officer | 2020年12月18日 A | — | 0 | 0 | $0 |
| Jing L. Marantz | 董事 | 2026年6月5日 A | 3131 | 0 | 0 | $0 |
| John Markels | 董事 | 2026年6月5日 A | 3131 | 0 | 0 | $0 |
| Moncef Slaoui | 董事 | 2026年6月5日 A | — | 0 | 0 | $0 |
| Magda Marquet | 董事 | 2026年6月5日 A | 3131 | 0 | 0 | $0 |
| Edward W Holmes | 董事 | 2026年6月5日 A | 3131 | 0 | 0 | $0 |
| James F Barlow | 董事 | 2026年6月5日 A | 13131 | 0 | 0 | $0 |
| FARRELL PETER C | 董事 | 2026年6月5日 A | 55741 | 0 | 0 | $0 |
| Ultragenyx Pharmaceutical Inc. | 董事 | 2021年8月11日 S | 1400000 | 0 | 0 | $0 |
| Karah Herdman Parschauer | 董事 | 2021年6月18日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. ×5 申报 | 2021年10月26日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 30 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1.96% | 2809043 NS | 2026年4月30日 | N-PORT |
| SBIO · ALPS ETF Trust | 0.14% | 29289 NS | 2026年5月31日 | N-PORT |
| IWC · iShares Trust | 0.04% | 90153 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 92163 SH | 2026年8月8日 | 每日 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 56780 NS | 2026年5月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.01% | 1526 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.01% | 189898 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.01% | 1052 NS | 2026年5月31日 | N-PORT |
| IWN · iShares Trust | 0.01% | 251572 SH | 2026年8月8日 | 每日 |
| GSSC · Goldman Sachs ETF Trust | 0.01% | 12950 NS | 2026年5月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 153611 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 23343 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.01% | 11122 NS | 2026年4月30日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 94563 NS | 2026年4月30日 | N-PORT |
| IWM · iShares Trust | 0.01% | 697947 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.01% | 1247 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.00% | 131117 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.00% | 976 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 985 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 25 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 730 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 24073 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 25985 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 6635 NS | 2026年5月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 8928 SH | 2026年8月8日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 3714 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 293104 SH | 2026年8月8日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 797154 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2156 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 71680 SH | 2026年8月8日 | 每日 |